Cardinal Health raises FY2025 non-GAAP EPS guidance to high end of $7.75-$7.90 range

CARDINAL HEALTH INC

Now expects FY2025 non-GAAP EPS toward high end of $7.75 to $7.90, driven by Pharmaceutical & Specialty Solutions strength.
Previous guidance range was $7.75-$7.90; update reflects improved segment performance.
Presenting at JP Morgan 43rd Annual Healthcare Conference on January 14, 2025.
Further details on FY2025 expectations to be provided on Q2 earnings call January 30, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.